Advanced company searchLink opens in new window

CAMBRIDGE PRECISION MEDICINE LIMITED

Company number 11107189

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
19 Feb 2019 PSC04 Change of details for Mr Edmund Joseph Lehmann as a person with significant control on 19 February 2019
22 Jan 2019 CH01 Director's details changed for Dr Manuel Jesus Corpas Lopez on 22 January 2019
22 Jan 2019 SH01 Statement of capital following an allotment of shares on 3 December 2018
  • GBP 150
21 May 2018 PSC04 Change of details for Mr Edmund Joseph Lehmann as a person with significant control on 21 May 2018
21 May 2018 PSC04 Change of details for Dr Manuel Jesus Corpas Lopez as a person with significant control on 21 May 2018
15 May 2018 RP04SH01 Second filing of a statement of capital following an allotment of shares on 15 March 2018
  • GBP 100
09 May 2018 CH01 Director's details changed for Mr Edmund Joseph Lehmann on 9 May 2018
09 May 2018 CH01 Director's details changed for Dr Manuel Jesus Corpas Lopez on 9 May 2018
08 May 2018 AD01 Registered office address changed from Lynton House 7-12 Tavistock Square London WC1H 9LT to Lynton House 7-12 7-12 Tavistock Square London WC1H 9LT on 8 May 2018
01 May 2018 AD01 Registered office address changed from Future Business Centre Kings Hedges Road Cambridge CB4 2HY United Kingdom to Lynton House 7-12 Tavistock Square London WC1H 9LT on 1 May 2018
19 Mar 2018 PSC04 Change of details for Dr Manuel Jesus Corpas Lopez as a person with significant control on 19 March 2018
19 Mar 2018 CH01 Director's details changed for Dr Manuel Corpas on 15 March 2018
15 Mar 2018 SH01 Statement of capital following an allotment of shares on 15 March 2018
  • GBP 50,000
  • ANNOTATION Clarification a second filed SH01 was registered on 15/05/2018.
15 Mar 2018 PSC01 Notification of Edmund Joseph Lehmann as a person with significant control on 15 March 2018
08 Mar 2018 PSC04 Change of details for Dr Manuel Corpas as a person with significant control on 8 March 2018
08 Mar 2018 AP01 Appointment of Mr Edmund Joseph Lehmann as a director on 8 March 2018
12 Dec 2017 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2017-12-12
  • GBP 50